Histone deacetylase inhibitors have also been shown to affect Ewing sarcoma cell proliferation possibly through EWSR1::FLI1-mediated transcription and chromatin regulation, although they have yet to demonstrate a clear signal in clinical testing [37,38,39,40,41,42,43,44,45]. The gene discussed is FLI1; the disease is Ewing sarcoma.